Tonix Pharmaceuticals Holding (TNXP) Change in Cash (2010 - 2026)

Tonix Pharmaceuticals Holding's Change in Cash history runs 17 years deep, the most recent figure standing at -$23.8 million for Q1 2026.

• On a quarterly basis, Change in Cash fell 172.25% year-over-year to -$23.8 million in Q1 2026; TTM through Mar 2026 was $53.4 million, a 57.18% decrease from a year earlier, with the FY2025 full-year figure at $110.1 million, up 49.16% from the prior year.
• Change in Cash declined to -$23.8 million in Q1 2026 per TNXP's latest filing, from $18.5 million in the prior quarter.
• Across five years, Change in Cash topped out at $70.5 million in Q4 2024 and bottomed at -$48.3 million in Q1 2023.
• The 5-year median for Change in Cash is -$6.4 million (2025), against an average of $418117.6.
• Biggest YoY gain for Change in Cash was 2328.11% in 2022; the steepest drop was 358.19% in 2022.
• Year by year, Change in Cash stood at -$19.7 million in 2022, then surged by 190.81% to $17.9 million in 2023, then jumped by 293.38% to $70.5 million in 2024, then plunged by 73.84% to $18.5 million in 2025, then slumped by 228.94% to -$23.8 million in 2026.
• Per Business Quant, the three latest TNXP Change in Cash figures stand at -$23.8 million (Q1 2026), $18.5 million (Q4 2025), and $65.1 million (Q3 2025).